Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

References

• Gallagher EJ Leroith D Karnieli E The metabolic syndrome from insulin resistance to obesity and diabetes Endocrinol Metab Clin North Am 2008 37 3 559 579 18775352
   PubMed Web of Science ®Google Scholar
• Dincer UD Future therapeutic concepts Journal of Metabolic Syndrome 2011 1 1 102
   Google Scholar
• Dincer UD Araiza AG Knudson JD Molina PE Tune JD Sensitization of coronary alpha-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome Microcirculation 2006 13 7 587 595 16990217
   PubMed Web of Science ®Google Scholar
• Dincer UD Araiza A Knudson JD Shao CH Bidasee KR Tune JD Dysfunction of cardiac ryanodine receptors in the metabolic syndrome J Mol Cell Cardiol 2006 41 1 108 114 16793060
   PubMed Web of Science ®Google Scholar
• Dincer UD Cardiac beta-adrenoceptor expression is markedly depressed in Ossabaw swine model of cardiometabolic risk Int J Gen Med 2011 4 493 499 21760751
   PubMedGoogle Scholar
• Knudson JD Dincer UD Dick GM Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction Am J Physiol Heart Circ Physiol 2005 289 3 H1038 H1046 15894577
   PubMed Web of Science ®Google Scholar
• Knudson JD Dincer UD Zhang C Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction Am J Physiol Heart Circ Physiol 2005 289 1 H48 H56 15749744
   PubMed Web of Science ®Google Scholar
• Knudson JD Rogers PA Dincer UD Coronary vasomotor reactivity to endothelin-1 in the prediabetic metabolic syndrome Microcirculation 2006 13 3 209 218 16627363
   PubMed Web of Science ®Google Scholar
• Knudson JD Dincer UD Bratz IN Sturek M Dick GM Tune JD Mechanisms of coronary dysfunction in obesity and insulin resistance Microcirculation 2007 14 4–5 317 338 17613805
   PubMed Web of Science ®Google Scholar
• Peters AL Patient and treatment perspectives: revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk Cleve Clin J Med 2009 76 Suppl 5 S20 S27 19952300
   PubMedGoogle Scholar
• Abdul-Ghani MA DeFronzo RA Plasma glucose concentration and prediction of future risk of type 2 diabetes Diabetes Care 2009 32 Suppl 2 S194 S198 19875551
   PubMed Web of Science ®Google Scholar
• Abdul-Ghani MA DeFronzo RA Pathophysiology of prediabetes Curr Diab Rep 2009 9 3 193 199 19490820
   PubMed Web of Science ®Google Scholar
• DeFronzo RA Banerji M Bray GA Actos Now for the prevention of diabetes (ACT NOW) study BMC Endocr Disord 2009 9 17 19640291
   PubMed Web of Science ®Google Scholar
• DeFronzo RA Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus Diabetes 2009 58 4 773 795 19336687
   PubMed Web of Science ®Google Scholar
• DeFronzo RA Banerji MA Bray GA Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study Diabetologia 2010 53 3 435 445 20012012
   PubMed Web of Science ®Google Scholar
• Dincer UD Cardiac dysfunction in prediabetic metabolic syndrome; Is JTV 519 (K201) future therapy? IBC’s Drug Discovery Series 6’th Annual Meeting, Targeting Metabolic Disorders; Advancing the Efficacy, Safety and Selectivity of Metabolic Disease Therapeutics March 17–19, 2008 Chapel Hill, NC
   Google Scholar
• Zalesin KC Franklin BA Miller WM Peterson ED McCullough PA Impact of obesity on cardiovascular disease Med Clin North Am 2011 95 5 919 937 21855700
   PubMed Web of Science ®Google Scholar
• Waugh N Cummins E Royle P Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation Health Technol Assess 2010 14 36 1 248
   Web of Science ®Google Scholar
• Shyangdan DS Royle P Clar C Sharma P Waugh N Snaith A Glucagon-like peptide analogues for type 2 diabetes mellitus Cochrane Database Syst Rev 2011 10 CD006423 21975753
   PubMed Web of Science ®Google Scholar
• Pratley RE Salsali A Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes Curr Med Res Opin 2007 23 4 919 931 17407649
   PubMed Web of Science ®Google Scholar
• Goodman E Daniels SR Dolan LM Definition of metabolic syndrome J Pediatr 2007 150 4 e36 e37 17382096
   PubMedGoogle Scholar
• Grundy SM Benjamin IJ Burke GL Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation 1999 100 10 1134 1146 10477542
   PubMed Web of Science ®Google Scholar
• Hall JE Brands MW Zappe DH Onso-Galicia M Cardiovascular actions of insulin: are they important in long-term blood pressure regulation? Clin Exp Pharmacol Physiol 1995 22 10 689 700 8575104
   PubMed Web of Science ®Google Scholar
• Hall JE Brands MW Zappe DH Alonso GM Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations? Proc Soc Exp Biol Med 1995 208 4 317 329 7700881
   PubMed Web of Science ®Google Scholar
• Alpert MA Management of obesity cardiomyopathy Am J Med Sci 2001 321 4 237 241 11307865
   PubMed Web of Science ®Google Scholar
• Elliott EB Hasumi H Otani N K201 (JTV-519) alters the spatiotemporal properties of diastolic Ca(2+) release and the associated diastolic contraction during beta-adrenergic stimulation in rat ventricular cardiomyocytes Basic Res Cardiol 2011 106 6 1009 1022 21901290
   PubMed Web of Science ®Google Scholar
• Guner S Arioglu E Tay A Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage Mol Cell Biochem 2004 263 1–2 143 150 15524175
   PubMed Web of Science ®Google Scholar
• Kushnir A Marks AR The ryanodine receptor in cardiac physiology and disease Adv Pharmacol 2010 59 1 30 20933197
   PubMedGoogle Scholar
• Bidasee KR Dincer UD Besch HRJr Ryanodine receptor dysfunction in hearts of streptozotocin-induced diabetic rats Mol Pharmacol 2001 60 6 1356 1364 11723243
   PubMed Web of Science ®Google Scholar
• Bidasee KR Nallani K Henry B Dincer UD Besch HRJr Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts Mol Cell Biochem 2003 249 1–2 113 123 12956406
   PubMed Web of Science ®Google Scholar
• Bidasee KR Nallani K Besch HRJr Dincer UD Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2) J Pharmacol Exp Ther 2003 305 3 989 998 12606683
   PubMed Web of Science ®Google Scholar
• Bidasee KR Zhang Y Shao CH Diabetes increases formation of advanced glycation end products on sarco(endo)plasmic reticulum Ca2+-ATPase Diabetes 2004 53 2 463 473 14747299
   PubMed Web of Science ®Google Scholar
• Fleischer S Ogunbunmi EM Dixon MC Fleer EA Localization of Ca2+ release channels with ryanodine in junctional terminal cisternae of sarcoplasmic reticulum of fast skeletal muscle Proc Natl Acad Sci U S A 1985 82 21 7256 7259 2414773
   PubMed Web of Science ®Google Scholar
• Gaburjakova M Gaburjakova J Reiken S FKBP12 binding modulates ryanodine receptor channel gating J Biol Chem 2001 276 20 16931 16935 11279144
   PubMed Web of Science ®Google Scholar
• Lehnart SE Terrenoire C Reiken S Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias Proc Natl Acad Sci U S A 2006 103 20 7906 7910 16672364
   PubMed Web of Science ®Google Scholar
• Wehrens XH Lehnart SE Huang F FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death Cell 2003 113 7 829 840 12837242
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ Rockman HA Koch WJ Catecholamines, cardiac beta-adrenergic receptors, and heart failure Circulation 2000 101 14 1634 1637 10758041
   PubMed Web of Science ®Google Scholar
• Lehnart SE Wehrens XH Reiken S Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias Cell 2005 123 1 25 35 16213210
   PubMed Web of Science ®Google Scholar
• Wehrens XH Lehnart SE Reiken SR Marks AR Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor Circ Res 2004 94 6 e61 e70 15016728
   PubMed Web of Science ®Google Scholar
• Wehrens XH Lehnart SE Reiken S Vest JA Wronska A Marks AR Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression Proc Natl Acad Sci U S A 2006 103 3 511 518 16407108
   PubMed Web of Science ®Google Scholar
• Aracena P Tang W Hamilton SL Hidalgo C Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels Antioxid Redox Signal 2005 7 7–8 870 881 15998242
   PubMed Web of Science ®Google Scholar
• Zissimopoulos S Docrat N Lai FA Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein J Biol Chem 2007 282 10 6976 6983 17200109
   PubMed Web of Science ®Google Scholar
• Yamaguchi N Xu L Pasek DA Evans KE Meissner G Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor) J Biol Chem 2003 278 26 23480 23486 12707260
   PubMed Web of Science ®Google Scholar
• Yamaguchi N Xu L Evans KE Pasek DA Meissner G Different regions in skeletal and cardiac muscle ryanodine receptors are involved in transducing the functional effects of calmodulin J Biol Chem 2004 279 35 36433 36439 15215235
   PubMed Web of Science ®Google Scholar
• Yamaguchi N Takahashi N Xu L Smithies O Meissner G Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel J Clin Invest 2007 117 5 1344 1353 17431507
   PubMed Web of Science ®Google Scholar
• Lokuta AJ Meyers MB Sander PR Fishman GI Valdivia HH Modulation of cardiac ryanodine receptors by sorcin J Biol Chem 1997 272 40 25333 25338 9312152
   PubMed Web of Science ®Google Scholar
• Farrell EF Antaramian A Rueda A Gomez AM Valdivia HH Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart J Biol Chem 2003 278 36 34660 34666 12824171
   PubMed Web of Science ®Google Scholar
• Gyorke I Gyorke S Regulation of the cardiac ryanodine receptor channel by luminal Ca2+ involves luminal Ca2+ sensing sites Biophys J 1998 75 6 2801 2810 9826602
   PubMed Web of Science ®Google Scholar
• Alpert MA Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome Am J Med Sci 2001 321 4 225 236 11307864
   PubMed Web of Science ®Google Scholar
• Taur Y Frishman WH The cardiac ryanodine receptor (RyR2) and its role in heart disease Cardiol Rev 2005 13 3 142 146 15831148
   PubMedGoogle Scholar
• Kushnir A Shan J Betzenhauser MJ Reiken S Marks AR Role of CaMKII delta phosphorylation of the cardiac ryanodine receptor in the force frequency relationship and heart failure Proc Natl Acad Sci U S A 2010 107 22 10274 10279 20479242
   PubMed Web of Science ®Google Scholar
• Wehrens XH Lehnart SE Reiken SR Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin 2 Science 2004 304 5668 292 296 15073377
   PubMed Web of Science ®Google Scholar
• Xiao B Tian X Xie W Functional consequence of protein kinase A-dependent phosphorylation of the cardiac ryanodine receptor: sensitization of store overload-induced Ca2+ release J Biol Chem 2007 282 41 30256 30264 17693412
   PubMed Web of Science ®Google Scholar
• Marks AR Reiken S Marx SO Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor? Circulation 2002 105 3 272 275 11804976
   PubMed Web of Science ®Google Scholar
• Marx SO Reiken S Hisamatsu Y PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts Cell 2000 101 4 365 376 10830164
   PubMed Web of Science ®Google Scholar
• Lehnart SE Wehrens XH Kushnir A Marks AR Cardiac ryanodine receptor function and regulation in heart disease Ann N Y Acad Sci 2004 1015 144 159 15201156
   PubMed Web of Science ®Google Scholar
• Battiprolu PK Gillette TG Wang ZV Lavandero S Hill JA Diabetic cardiomyopathy: mechanisms and therapeutic targets Drug Discov Today Dis Mech 2010 7 2 e135 e143 21274425
   PubMedGoogle Scholar
• Poornima IG Parikh P Shannon RP Diabetic cardiomyopathy: the search for a unifying hypothesis Circ Res 2006 98 5 596 605 16543510
   PubMed Web of Science ®Google Scholar
• Bidasee KR Nallani K Yu Y Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels Diabetes 2003 52 7 1825 1836 12829653
   PubMed Web of Science ®Google Scholar
• Khullar M Al-Shudiefat AA Ludke A Binepal G Singal PK Oxidative stress: a key contributor to diabetic cardiomyopathy Can J Physiol Pharmacol 2010 88 3 233 240 20393588
   PubMed Web of Science ®Google Scholar
• Liu GX Hanley PJ Ray J Daut J Long-chain acyl-coenzyme A esters and fatty acids directly link metabolism to K(ATP) channels in the heart Circ Res 2001 88 9 918 924 11349001
   PubMed Web of Science ®Google Scholar
• Heineke J Molkentin JD Regulation of cardiac hypertrophy by intracellular signalling pathways Nat Rev Mol Cell Biol 2006 7 8 589 600 16936699
   PubMed Web of Science ®Google Scholar
• Dzau VJ Bernstein K Celermajer D The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data Am J Cardiol 2001 88 9A 1L 20L 11423049
   PubMed Web of Science ®Google Scholar
• Dzau VJ Bernstein K Celermajer D Pathophysiologic and therapeutic importance of tissue ACE: a consensus report Cardiovasc Drugs Ther 2002 16 2 149 160 12090908
   PubMed Web of Science ®Google Scholar
• McMurray JJ Pfeffer MA Swedberg K Dzau VJ Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation 2004 110 20 3281 3288 15545527
   PubMed Web of Science ®Google Scholar
• Erhardt LR A review of the current evidence for the use of angiotensin- receptor blockers in chronic heart failure Int J Clin Pract 2005 59 5 571 578 15857354
   PubMed Web of Science ®Google Scholar
• Eisenberg MJ Gioia LC Angiotensin II receptor blockers in congestive heart failure Cardiol Rev 2006 14 1 26 34 16371763
   PubMedGoogle Scholar
• Taylor AA Bakris GL The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome Am J Med 2010 123 7 Suppl 1 S21 S26 20609696
   PubMed Web of Science ®Google Scholar
• Toischer K Lehnart SE Tenderich G K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum Basic Res Cardiol 2010 105 2 279 287 19718543
   PubMed Web of Science ®Google Scholar
• Kaneko N Matsuda R Hata Y Shimamoto K Pharmacological characteristics and clinical applications of K201 Curr Clin Pharmacol 2009 4 2 126 131 19442077
   PubMedGoogle Scholar
• Kimura J Kawahara M Sakai E Yatabe J Nakanishi H Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes Jpn J Pharmacol 1999 79 3 275 281 10230854
   PubMedGoogle Scholar
• Kiriyama K Kiyosue T Wang JC Dohi K Arita M Effects of JTV-519, a novel anti-ischaemic drug, on the delayed rectifier K+ current in guinea-pig ventricular myocytes Naunyn Schmiedebergs Arch Pharmacol 2000 361 6 646 653 10882040
   PubMed Web of Science ®Google Scholar
• Nakaya H Furusawa Y Ogura T Tamagawa M Uemura H Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts Br J Pharmacol 2000 131 7 1363 1372 11090108
   PubMed Web of Science ®Google Scholar
• Hasumi H Matsuda R Shimamoto K Hata Y Kaneko N K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization Eur J Pharmacol 2007 555 1 54 60 17112502
   PubMed Web of Science ®Google Scholar
• Hunt DJ Jones PP Wang R K201 (JTV519) suppresses spontaneous Ca2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association Biochem J 2007 404 3 431 438 17313373
   PubMed Web of Science ®Google Scholar
• James AF Inhibition of SR Ca2+ uptake: a novel action of the RyR2-FKBP12.6 antagonist K201 Cardiovasc Res 2007 76 2 199 201 17869231
   PubMed Web of Science ®Google Scholar
• Jones PP Jiang D Bolstad J Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload- induced Ca2+ release Biochem J 2008 412 1 171 178 18092949
   PubMed Web of Science ®Google Scholar
• Berwick ZC Dick GM Moberly SP Kohr MC Sturek M Tune JD Contribution of voltage-dependent K(+) channels to metabolic control of coronary blood flow J Mol Cell Cardiol 2012 52 4 912 919 21771599
   PubMed Web of Science ®Google Scholar
• Borbouse L Dick GM Asano S Impaired function of coronary BK(Ca) channels in metabolic syndrome Am J Physiol Heart Circ Physiol 2009 297 5 H1629 H1637 19749164
   PubMed Web of Science ®Google Scholar
• Kumagai K Nakashima H Gondo N Saku K Antiarrhythmic effects of JTV-519, a novel cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model J Cardiovasc Electrophysiol 2003 14 8 880 884 12890053
   PubMed Web of Science ®Google Scholar